DNLI - Denali Therapeutics GAAP EPS of -$0.62 misses by $0.16 revenue of $12.51M misses by $32.31M
Denali Therapeutics press release (NASDAQ:DNLI): Q4 GAAP EPS of -$0.62 misses by $0.16. Revenue of $12.51M (-96.1% Y/Y) misses by $32.31M.
For further details see:
Denali Therapeutics GAAP EPS of -$0.62 misses by $0.16, revenue of $12.51M misses by $32.31M